Showing 1 - 20 results of 32 for search 'Loquai S.', query time: 0.05s Refine Results
  1. 1
    Acute low back pain as infusion-related reaction to monoclonal antibodies

    Acute low back pain as infusion-related reaction to monoclonal antibodies by Pawel Majenka, Carmen Loquai, Tilman Schöning, Alexander Enk, Jessica Hassel

    Published 2023-10-01
    Get full text
    Article
  2. 2
    Thermochromic VO2 films for smart windows application

    Thermochromic VO2 films for smart windows application by Azzi M., Slim R., Khoury K., Loquai S., Baloukas B., Martinu L.

    Published 2019-01-01
    Get full text
    Article
  3. 3
    Poliosis Is Associated with Response to Checkpoint-Inhibitor Therapy: A Case Report of Two Patients with Multifocal Metastatic Melanoma

    Poliosis Is Associated with Response to Checkpoint-Inhibitor Therapy: A Case Report of Two Patients with Multifocal Metastatic Melanoma by Maximilian Haist, Henner Stege, Verena Maikranz, Maria Halley Blanco, Stephan Grabbe, Carmen Loquai

    Published 2022-03-01
    Get full text
    Article
  4. 4
    The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma—A Retrospective, Real-World Cohort Study

    The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma—A Retrospe... by Maximilian Haist, Henner Stege, Ronja Ebner, Maria Isabel Fleischer, Carmen Loquai, Stephan Grabbe

    Published 2022-04-01
    Get full text
    Article
  5. 5
    Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immunofluorescence Study

    Role of Hypoxia and the Adenosine System in Immune Evasion and Prognosis of Patients with Brain Metastases of Melanoma: A Multiplex Whole Slide Immunofluorescence Study by Arnulf Mayer, Maximilian Haist, Carmen Loquai, Stephan Grabbe, Matthias Rapp, Wilfried Roth, Peter Vaupel, Heinz Schmidberger

    Published 2020-12-01
    Get full text
    Article
  6. 6
    Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis

    Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivi... by Ralf Gutzmer, Caroline Robert, Carmen Loquai, Dirk Schadendorf, Nicholas Squittieri, Ramon Arntz, Serena Martelli, Reinhard Dummer

    Published 2021-11-01
    Get full text
    Article
  7. 7
    Screening for distress in routine oncological care-a survey in 520 melanoma patients.

    Screening for distress in routine oncological care-a survey in 520 melanoma patients. by Carmen Loquai, Vera Scheurich, Nils Syring, Irene Schmidtmann, Stephan Rietz, Andreas Werner, Stephan Grabbe, Manfred E Beutel

    Published 2013-01-01
    Get full text
    Article
  8. 8
    Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors—A Retrospective, Real-World Cohort Study

    Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune... by Maximilian Haist, Henner Stege, Saskia Pemler, Jaqueline Heinz, Maria Isabel Fleischer, Claudine Graf, Wolfram Ruf, Carmen Loquai, Stephan Grabbe

    Published 2021-10-01
    Get full text
    Article
  9. 9
    In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET

    In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET by Stefanie Pektor, Lina Hilscher, Kerstin C. Walzer, Isabelle Miederer, Nicole Bausbacher, Carmen Loquai, Mathias Schreckenberger, Ugur Sahin, Mustafa Diken, Matthias Miederer

    Published 2018-08-01
    Get full text
    Article
  10. 10
    Platelet-Derived GARP Induces Peripheral Regulatory T Cells—Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis

    Platelet-Derived GARP Induces Peripheral Regulatory T Cells—Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis by Niklas Zimmer, Franziska K. Krebs, Sophia Zimmer, Heidrun Mitzel-Rink, Elena J. Kumm, Kerstin Jurk, Stephan Grabbe, Carmen Loquai, Andrea Tuettenberg

    Published 2020-12-01
    Get full text
    Article
  11. 11
    Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma

    Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma by Franziska K. Krebs, Emily R. Trzeciak, Sophia Zimmer, Deniz Özistanbullu, Heidrun Mitzel‐Rink, Markus Meissner, Stephan Grabbe, Carmen Loquai, Andrea Tuettenberg

    Published 2021-03-01
    Get full text
    Article
  12. 12
    Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study

    Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study by Martin Salzmann, Alexander Wald, Henner Stege, Carmen Loquai, Lisa Zimmer, Kinan M. Hayani, Lucie Heinzerling, Ralf Gutzmer, Alexander H. Enk, Jessica C. Hassel

    Published 2023-02-01
    Get full text
    Article
  13. 13
    391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab in advanced solid tumors

    391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab... by Evelyna Derhovanessian, Nicolas Acquavella, Christophe Massard, Carmen Loquai, Jochen Utikal, Jean-Francois Baurain, Oliver Bechter, Marie-Laure Ozoux, Rahul Marpadga, Esteban-Rodrigo Imedio

    Published 2020-11-01
    Article
  14. 14
    Willingness to pay for a cure of low-risk melanoma patients in Germany.

    Willingness to pay for a cure of low-risk melanoma patients in Germany. by Matthias Augustin, Christine Blome, Andrea Forschner, Ralf Gutzmer, Axel Hauschild, Lucie Heinzerling, Elisabeth Livingstone, Carmen Loquai, Dirk Schadendorf, Jochen Utikal, Tobias Wagner, Sophia Wilden, Katharina C Kähler

    Published 2018-01-01
    Get full text
    Article
  15. 15
    Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks

    Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 wee... by Michael Migden, MD, Carmen Loquai, MD, PhD, Caroline Robert, MD, PhD, Jean-François Baurain, MD, PhD, Nicholas Squittieri, MD, Ramon Arntz, Dr, Jörg Dierlamm, BSc, Brigitte Dréno, MD, PhD

    Published 2023-03-01
    Get full text
    Article
  16. 16
    COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma

    COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma by Carola Berking, Elisabeth Livingstone, Dirk Debus, Carmen Loquai, Michael Weichenthal, Ulrike Leiter, Felix Kiecker, Peter Mohr, Thomas K. Eigentler, Janina Remy, Katharina Schober, Markus V. Heppt, Imke von Wasielewski, Dirk Schadendorf, Ralf Gutzmer

    Published 2023-09-01
    Get full text
    Article
  17. 17
    Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers

    Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers by Christian D. Sadik, Christian D. Sadik, Ewan A. Langan, Ewan A. Langan, Ralf Gutzmer, Maria Isabel Fleischer, Carmen Loquai, Lydia Reinhardt, Friedegund Meier, Daniela Göppner, Rudolf A. Herbst, Detlef Zillikens, Detlef Zillikens, Patrick Terheyden

    Published 2021-02-01
    Get full text
    Article
  18. 18
    Pimasertib Versus Dacarbazine in Patients With Unresectable <i>NRAS</i>-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

    Pimasertib Versus Dacarbazine in Patients With Unresectable <i>NRAS</i>-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover by Celeste Lebbé, Caroline Dutriaux, Thierry Lesimple, Willem Kruit, Joseph Kerger, Luc Thomas, Bernard Guillot, Filippo de Braud, Claus Garbe, Jean-Jacques Grob, Carmen Loquai, Virginia Ferraresi, Caroline Robert, Paul Vasey, Robert Conry, Richard Isaacs, Enrique Espinosa, Armin Schueler, Giorgio Massimini, Brigitte Dréno

    Published 2020-06-01
    Get full text
    Article
  19. 19
    Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry

    Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the Germa... by Maximilian Haist, Henner Stege, Berenice Mareen Lang, Aikaterini Tsochataridou, Martin Salzmann, Peter Mohr, Dirk Schadendorf, Selma Ugurel, Jan-Malte Placke, Michael Weichenthal, Ralf Gutzmer, Ulrike Leiter, Martin Kaatz, Sebastian Haferkamp, Carola Berking, Markus Heppt, Barbara Tschechne, Patrick Schummer, Christoffer Gebhardt, Stephan Grabbe, Carmen Loquai

    Published 2022-11-01
    Get full text
    Article
  20. 20
    Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

    Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions by Antje Sucker, Fang Zhao, Natalia Pieper, Christina Heeke, Raffaela Maltaner, Nadine Stadtler, Birgit Real, Nicola Bielefeld, Sebastian Howe, Benjamin Weide, Ralf Gutzmer, Jochen Utikal, Carmen Loquai, Helen Gogas, Ludger Klein-Hitpass, Michael Zeschnigk, Astrid M. Westendorf, Mirko Trilling, Susanne Horn, Bastian Schilling, Dirk Schadendorf, Klaus G. Griewank, Annette Paschen

    Published 2017-05-01
    Get full text
    Article

Search Tools: